These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16998544)

  • 21. Promises of biomarkers in drug development--a reality check.
    Marrer E; Dieterle F
    Chem Biol Drug Des; 2007 Jun; 69(6):381-94. PubMed ID: 17581232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress in pharmacogenomics and its promise for medicine.
    Blake CA; Sobel BE
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1482-3. PubMed ID: 18849537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzymes and pharmacogenetics of cardiovascular drugs.
    Siest G; Jeannesson E; Visvikis-Siest S
    Clin Chim Acta; 2007 May; 381(1):26-31. PubMed ID: 17362901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of pharmacogenomics.
    Somogy A
    Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should pharmacogenomic studies be required for new drug approval?
    Relling MV; Hoffman JM
    Clin Pharmacol Ther; 2007 Mar; 81(3):425-8. PubMed ID: 17339872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacogenetics and tailored drug therapy].
    Nielsen FC; Borregaard N
    Ugeskr Laeger; 2009 Mar; 171(10):790-4. PubMed ID: 19265602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates.
    Kramer JA; Sagartz JE; Morris DL
    Nat Rev Drug Discov; 2007 Aug; 6(8):636-49. PubMed ID: 17643090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.
    Owen RP; Altman RB; Klein TE
    Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Connecting chemosensitivity, gene expression and disease.
    Covell DG
    Trends Pharmacol Sci; 2008 Jan; 29(1):1-5. PubMed ID: 18055024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is personalized medicine finally arriving?
    Allison M
    Nat Biotechnol; 2008 May; 26(5):509-17. PubMed ID: 18464779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular medicine hones therapeutic arts to science.
    Waldman SA; Terzic MR; Terzic A
    Clin Pharmacol Ther; 2007 Oct; 82(4):343-7. PubMed ID: 17851568
    [No Abstract]   [Full Text] [Related]  

  • 32. Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome.
    Mourad M; Wallemacq P; De Meyer M; Malaise J; De Pauw L; Eddour DC; Goffin E; Lerut J; Haufroid V
    Transplantation; 2008 Apr; 85(7 Suppl):S19-24. PubMed ID: 18401258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacogenetics of antiplatelet drugs.
    Marín F; Roldán V; González-Conejero R; Corral J
    Curr Opin Investig Drugs; 2007 Mar; 8(3):213-8. PubMed ID: 17408116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytochromes P450: decision-making tools for personalized therapeutics.
    Murray M; Petrovic N
    Curr Opin Mol Ther; 2006 Dec; 8(6):480-6. PubMed ID: 17243482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal cancer therapeutics and the challenges of applied pharmacogenomics.
    Kruzelock RP; Short W
    Curr Probl Cancer; 2007; 31(5):315-66. PubMed ID: 17905192
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacogenetics in cardiovascular antithrombotic therapy.
    Marín F; González-Conejero R; Capranzano P; Bass TA; Roldán V; Angiolillo DJ
    J Am Coll Cardiol; 2009 Sep; 54(12):1041-57. PubMed ID: 19744613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of pharmacogenetics in treating central nervous system disorders.
    Patnaik M; Renda MJ; Athanasiou MC; Reed CR
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1504-9. PubMed ID: 18849543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics in hemostasis: friend or foe?
    Rumilla K; Chen D; Baudhuin LM
    Semin Thromb Hemost; 2009 Feb; 35(1):42-9. PubMed ID: 19308892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetics in Europe: barriers and opportunities.
    Gurwitz D; Zika E; Hopkins MM; Gaisser S; Ibarreta D
    Public Health Genomics; 2009; 12(3):134-41. PubMed ID: 19204415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What will it take to reap the clinical benefits of pharmacogenomics?
    Evans BJ
    Food Drug Law J; 2006; 61(4):753-94. PubMed ID: 17180771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.